Pang S - Search Results

1

In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector.

Toloza EM, Hunt K, Swisher S, McBride W, Lau R, Pang S, Rhoades K, Drake T, Belldegrun A, Glaspy J, Economou JS. Toloza EM, et al. Among authors: pang s. Cancer Gene Ther. 1996 Jan-Feb;3(1):11-7. Cancer Gene Ther. 1996. PMID: 8785705

2

In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.

Hathorn RW, Tso CL, Kaboo R, Pang S, Figlin R, Sawyers C, deKernion JB, Belldegrun A. Hathorn RW, et al. Among authors: pang s. Cancer. 1994 Oct 1;74(7):1904-11. doi: 10.1002/1097-0142(19941001)74:7<1904::aid-cncr2820740713>3.0.co;2-b. Cancer. 1994. PMID: 7521786

3

Gene therapy: principles and potential.

Taneja SS, Pang S, Cohan P, Belldegrun A. Taneja SS, et al. Among authors: pang s. Cancer Surv. 1995;23:247-66. Cancer Surv. 1995. PMID: 7542564 Review.

4

Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer.

Pang S, Taneja S, Dardashti K, Cohan P, Kaboo R, Sokoloff M, Tso CL, Dekernion JB, Belldegrun AS. Pang S, et al. Hum Gene Ther. 1995 Nov;6(11):1417-26. doi: 10.1089/hum.1995.6.11-1417. Hum Gene Ther. 1995. PMID: 8573614

5

Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen.

Pang S, Dannull J, Kaboo R, Xie Y, Tso CL, Michel K, deKernion JB, Belldegrun AS. Pang S, et al. Cancer Res. 1997 Feb 1;57(3):495-9. Cancer Res. 1997. PMID: 9012480

6

Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinoma.

Mulders P, Tso CL, Pang S, Kaboo R, McBride WH, Hinkel A, Gitlitz B, Dannull J, Figlin R, Belldegrun A. Mulders P, et al. Among authors: pang s. J Immunother. 1998 May;21(3):170-80. doi: 10.1097/00002371-199805000-00002. J Immunother. 1998. PMID: 9610908

7

In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.

Sokoloff MH, Tso CL, Kaboo R, Taneja S, Pang S, deKernion JB, Belldegrun AS. Sokoloff MH, et al. Among authors: pang s. Cancer. 1996 May 1;77(9):1862-72. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1862::AID-CNCR16>3.0.CO;2-Y. Cancer. 1996. PMID: 8646686

8

Highly efficient and consistent gene transfer into dendritic cells utilizing a combination of ultraviolet-irradiated adenovirus and poly(L-lysine) conjugates.

Mulders P, Pang S, Dannull J, Kaboo R, Hinkel A, Michel K, Tso CL, Roth M, Belldegrun A. Mulders P, et al. Among authors: pang s. Cancer Res. 1998 Mar 1;58(5):956-61. Cancer Res. 1998. PMID: 9500456

9

Regression of prostate cancer xenografts by a lentiviral vector specifically expressing diphtheria toxin A.

Zheng JY, Chen D, Chan J, Yu D, Ko E, Pang S. Zheng JY, et al. Among authors: pang s. Cancer Gene Ther. 2003 Oct;10(10):764-70. doi: 10.1038/sj.cgt.7700629. Cancer Gene Ther. 2003. PMID: 14502229

10

Targeting and eradicating cancer cells by a prostate-specific vector carrying the diphtheria toxin A gene.

Pang S. Pang S. Cancer Gene Ther. 2000 Jul;7(7):991-6. doi: 10.1038/sj.cgt.7700197. Cancer Gene Ther. 2000. PMID: 10917201

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,043 results

Search Page

Filters